Fei Chen

ORCID: 0000-0002-5819-1490
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • Epigenetics and DNA Methylation
  • Endoplasmic Reticulum Stress and Disease
  • Cancer Immunotherapy and Biomarkers

Chinese Academy of Medical Sciences & Peking Union Medical College
2022-2023

High CD8+ T cell infiltration in colorectal cancer (CRC) should suggest a favorable prognosis and satisfactory response to immunotherapy; however, the vast majority of patients with CRC do not benefit from immunotherapy due poor infiltration. Therefore, better understanding mechanisms for exclusion tumors is needed. Tribbles homolog 3 (TRIB3) has been implicated as an oncoprotein, but its role regulating antitumor immune responses defined. Here, we demonstrated that TRIB3 inhibits various...

10.1126/scitranslmed.abf0992 article EN Science Translational Medicine 2022-01-05

Elimination of cancer stem cells (CSCs) and reinvigoration antitumor immunity remain unmet challenges for therapy. Tumor-associated macrophages (TAMs) constitute the prominant population immune in tumor tissues, contributing to formation CSC niches a suppressive microenvironment. Here, we report that high expression inhibitor differentiation 1 (ID1) TAMs correlates with poor outcome patients colorectal (CRC). ID1 expressing maintain stemness impede CD8+ T cell infiltration. Mechanistically,...

10.1038/s41467-023-43548-w article EN cc-by Nature Communications 2023-11-23
Coming Soon ...